Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa

BACKGROUND: The introduction of Bedaquiline, the first new antimycobacterial drug in over 40 years, has highlighted the critical importance of medication adherence in drug-resistant tuberculosis (DR-TB) treatment to prevent amplified drug-resistance and derive sustained benefit. Real-time electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bionghi, N., Daftary, A., Maharaj, B., Msibi, Z., Amico, K. R., Friedland, G., Orrell, C., Padayatchi, N., O’Donnell, M. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896111/
https://www.ncbi.nlm.nih.gov/pubmed/29642874
http://dx.doi.org/10.1186/s12879-018-3080-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896111/
https://www.ncbi.nlm.nih.gov/pubmed/29642874
http://dx.doi.org/10.1186/s12879-018-3080-2

Ejemplares similares